72 related articles for article (PubMed ID: 10761012)
1. Cutaneous T-cell Lymphoma.
Glass LF; Keller KL; Messina JL; Dalton J; Yag-Howard C; Fenske NA
Cancer Control; 1998 Jan; 5(1):11-18. PubMed ID: 10761012
[TBL] [Abstract][Full Text] [Related]
2. The diagnosis, staging, and treatment options for mycosis fungoides.
Keehn CA; Belongie IP; Shistik G; Fenske NA; Glass LF
Cancer Control; 2007 Apr; 14(2):102-11. PubMed ID: 17387295
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous T-cell lymphoma.
Williams DS
J Insur Med; 2006; 38(2):147-50. PubMed ID: 16845850
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
Edelson RL
Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
[TBL] [Abstract][Full Text] [Related]
5. Primary cutaneous T-cell lymphoma: review and current concepts.
Siegel RS; Pandolfino T; Guitart J; Rosen S; Kuzel TM
J Clin Oncol; 2000 Aug; 18(15):2908-25. PubMed ID: 10920140
[TBL] [Abstract][Full Text] [Related]
6. T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings.
Ponti R; Quaglino P; Novelli M; Fierro MT; Comessatti A; Peroni A; Bonello L; Bernengo MG
Br J Dermatol; 2005 Sep; 153(3):565-73. PubMed ID: 16120144
[TBL] [Abstract][Full Text] [Related]
7. Transformation of cutaneous T cell lymphoma to large cell lymphoma. A clinicopathologic and immunologic study.
Salhany KE; Cousar JB; Greer JP; Casey TT; Fields JP; Collins RD
Am J Pathol; 1988 Aug; 132(2):265-77. PubMed ID: 3261136
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous T-cell lymphoma (CTCL): Current practices in blood assessment and the utility of T-cell receptor (TCR)-Vβ chain restriction.
Gibson JF; Huang J; Liu KJ; Carlson KR; Foss F; Choi J; Edelson R; Hussong JW; Mohl R; Hill S; Girardi M
J Am Acad Dermatol; 2016 May; 74(5):870-7. PubMed ID: 26874819
[TBL] [Abstract][Full Text] [Related]
9. Overall survival in erythrodermic cutaneous T-cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma.
Vidulich KA; Talpur R; Bassett RL; Duvic M
Int J Dermatol; 2009 Mar; 48(3):243-52. PubMed ID: 19261011
[TBL] [Abstract][Full Text] [Related]
10. Analysis of clonality in cutaneous T cell lymphoma and associated diseases.
Wood GS
Ann N Y Acad Sci; 2001 Sep; 941():26-30. PubMed ID: 11594579
[TBL] [Abstract][Full Text] [Related]
11. Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-cell lymphomas.
Bosisio FM; Cerroni L
Am J Dermatopathol; 2015 Feb; 37(2):115-21. PubMed ID: 25406852
[TBL] [Abstract][Full Text] [Related]
12. Comparative study of cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma.
Nagatani T; Miyazawa M; Matsuzaki T; Iemoto G; Kim ST; Baba N; Miyamoto H; Nakajima H
Semin Dermatol; 1994 Sep; 13(3):216-22. PubMed ID: 7986691
[TBL] [Abstract][Full Text] [Related]
13. TCR sequencing facilitates diagnosis and identifies mature T cells as the cell of origin in CTCL.
Kirsch IR; Watanabe R; O'Malley JT; Williamson DW; Scott LL; Elco CP; Teague JE; Gehad A; Lowry EL; LeBoeuf NR; Krueger JG; Robins HS; Kupper TS; Clark RA
Sci Transl Med; 2015 Oct; 7(308):308ra158. PubMed ID: 26446955
[TBL] [Abstract][Full Text] [Related]
14. Second Primary Malignancies in CTCL Patients from 1992 to 2011: A SEER-Based, Population-Based Study Evaluating Time from CTCL Diagnosis, Age, Sex, Stage, and CD30+ Subtype.
Amber KT; Bloom R; Nouri K
Am J Clin Dermatol; 2016 Feb; 17(1):71-7. PubMed ID: 26386881
[TBL] [Abstract][Full Text] [Related]
15. Large-cell transformation following detection of minimal residual disease in cutaneous T-cell lymphoma: molecular and in situ analysis of a single neoplastic T-cell clone expressing the identical T-cell receptor.
Wolfe JT; Chooback L; Finn DT; Jaworsky C; Rook AH; Lessin SR
J Clin Oncol; 1995 Jul; 13(7):1751-7. PubMed ID: 7602365
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical staining for CD45R isoforms in paraffin sections to diagnose mycosis fungoides-type cutaneous T-cell lymphoma.
Ismail SA; Han R; Sanborn SL; Stevens SR; Cooper KD; Wood GS; Gilliam AC
J Am Acad Dermatol; 2007 Apr; 56(4):635-42. PubMed ID: 17367612
[TBL] [Abstract][Full Text] [Related]
17. The pathology of cutaneous T-cell lymphoma.
Robson A
Oncology (Williston Park); 2007 Feb; 21(2 Suppl 1):9-12. PubMed ID: 17474353
[TBL] [Abstract][Full Text] [Related]
18. T-cell receptor gamma gene rearrangement in cutaneous T-cell lymphoma: comparative study of polymerase chain reaction with denaturing gradient gel electrophoresis and GeneScan analysis.
Goeldel AL; Cornillet-Lefebvre P; Durlach A; Birembaut P; Bernard P; Nguyen P; Grange F
Br J Dermatol; 2010 Apr; 162(4):822-9. PubMed ID: 19906072
[TBL] [Abstract][Full Text] [Related]
19. Current status of cutaneous T-cell lymphoma: molecular diagnosis, pathogenesis, therapy and future directions.
Dippel E; Klemke CD; Goerdt S
Onkologie; 2003 Oct; 26(5):477-83. PubMed ID: 14605466
[TBL] [Abstract][Full Text] [Related]
20. The applicability of T-cell receptor gamma gene rearrangement as an adjuvant diagnostic tool in skin biopsies for cutaneous T-cell lymphoma.
Khalil SH; Hamadah IR
Saudi Med J; 2006 Jul; 27(7):951-4. PubMed ID: 16830010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
